Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20094044.
- Also identified by DOI 10.1038/nrc2773 and PMC identifier 2879265.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The public health importance of Barrett's oesophagus lies in its association with oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma has risen at an alarming rate over the past four decades in many regions of the Western world, and there are indications that the incidence of this disease is on the rise in Asian populations in which it has been rare. Much has been learned of host and environmental risk factors that affect the incidence of oesophageal adenocarcinoma, and data indicate that patients with Barrett's oesophagus rarely develop oesophageal adenocarcinoma. Given that 95% of oesophageal adenocarcinomas arise in individuals without a prior diagnosis of Barrett's oesophagus, what strategies can be used to reduce late diagnosis of oesophageal adenocarcinoma?
Medical subject headings
- Adenocarcinoma
- Barrett Esophagus
- Esophageal Neoplasms